In the context of bladder cancer, BCG therapy involves direct instillation of the vaccine into the bladder. This local treatment harnesses the body's immune system to attack cancer cells, reducing the risk of cancer recurrence. The mechanism of action is not fully understood, but it is believed to involve a complex interaction between BCG, bladder cells, and the immune system, leading to the destruction of cancerous tissues.
